Italy on Friday announced an end to lockdown measures from next week for Lombardy, the epicentre of its coronavirus pandemic, and several other regions with improving contagion statistics.
What you need to know about the J&J vaccine
European regulators are reviewing side effects of Johnson & Johnson’s single-dose COVID-19 shot, after a handful of cases of rare blood clots were reported among its recipients.
Amazon Workers Defeat Union Effort in Alabama
The company’s decisive victory deals a crushing blow to organized labor, which had hoped the time was ripe to start making inroads.
Pfizer seeks COVID vaccine authorization for 12-15 year olds in US
Pfizer-BioNTech asked for authorization Friday to use their COVID-19 vaccine on 12-15 year olds in the United States.
Half of weekly AZ vaccine deliveries to EU delayed: company
Half of AstraZeneca’s vaccine shipments to the European Union will be delayed this week, a company spokesman told AFP Friday, as much of the bloc works to speed up a slow rollout of COVID jabs.
The most-viewed YouTube videos of all time
Over a decade later, YouTube now has trillions of views across billions of videos. Here are some of the most-viewed YouTube videos. Which ones have you seen?
How long does it take to beat Outriders?
Outriders isn’t a live service game, but there’s still a lot of content packed into the co-op shooter. Here’s how long it’ll take to beat the main campaign.
Vaccines and functional neurological disorder: A complex story, say experts
Videos of people experiencing severe neurological symptoms, including convulsions and difficulty walking, purportedly after receiving a COVID-19 vaccine, have surfaced on Facebook, YouTube and other social media channels. The millions of people watching these videos might conclude that the vaccine is either quite dangerous to produce such symptoms or that the people in the videos …
Children less infectious than adults with SARS-CoV-2
Children may not be as infectious in spreading SARS-CoV-2 to others as previously thought, according to new University of Manitoba-led research in CMAJ (Canadian Medical Association Journal).
Geography, job risk should be factors in prioritizing SARS-CoV-2 vaccinations
When setting SARS-CoV-2 vaccine priorities, Canada should take a more nuanced approach that considers geographic and occupational risk exposures, as 75% of Canadian adults have at least 1 risk factor for severe COVID-19, argues an analysis in CMAJ (Canadian Medical Association Journal).